|Bid||29.50 x N/A|
|Ask||30.00 x N/A|
|Day's Range||29.00 - 30.00|
|52 Week Range||4.72 - 33.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 30, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Federal government increasing state allotment of vaccines. Meanwhile, U.K. begins first human challenge trials.
Open Orphan (AIM:ORPH) announced the world’s first COVID-19 characterization study has received ethics approval in the UK.
Scientists are studying booster shots and/or new vaccines that can protect against the evolving virus or specific strains as coronavirus variants spread around the globe.